MediSwipe Inc. Announces Exclusive Distribution Agreement for Hemp Based Energy Drink "CHILLO" and Hemp Ice Tea "C+SWISS" Adding Beverage Division for US Medical Dispensaries in 19 States and District of Columbia With Chill Drinks, LLC

LOS ANGELES, April 29, 2013 (GLOBE NEWSWIRE) -- MediSwipe Inc. ( (OTCBB:MWIP), a patient security solutions and partner company for the medicinal marijuana and health care industry, today announced an exclusive agreement for the sale and distribution of hemp based energy drinks and hemp based teas to medicinal dispensaries throughout the United States with Chill Drinks LLC of Miami, Florida. MediSwipe now plans to create a new distribution division to sell the popular hemp based energy drink "CHILLO" and hemp ice tea C+SWISS to all licensed medical dispensaries in 19 states and the District of Columbia.

C+SWISS is popularly known as the original hemp based ice tea approved for sale in the United States, with distribution already in Whole Foods and major markets nationally. The hemp based drink comes in eco-friendly, recyclable packaging that stands out to the health conscious target customer. C+SWISS contains all natural ingredients including non-gmo beet sugar, concentrated lemon juice, hemp seed extract, black tea extract, and natural flavoring consisting of fruit and plant extracts.

CHILLO, with its distinct trademark orange can, carries the chill of hemp seed extract with the added punch and perfect blend of caffeine, vitamins B6 and B12 for the ultimate drink experience. Both brands will be available in dispensaries across the country starting next week, and may be ordered for dispensaries exclusively through MediSwipe by calling 248.262.6850 or through email at

"We are extremely excited to have solidified this partnership with Chill Drinks, as we believe we represent the ideal network and audience to take these products to the next level. Before our first pallets are hitting the warehouses here in Michigan, the orders from our dispensary clients are already exceeding our expectations. We are shipping to Michigan first, with products going to California and Colorado in May where we already have sales representatives writing orders. We are planning a grassroots marketing campaign, starting in Ann Arbor, at the University of Michigan with 50,000 students and a very friendly medicinal marijuana town. We plan to offer an alternative to morning coffee and the well known energy drinks with CHILLO as it provides the added benefits of hemp seed extract with a kick," stated Michael Friedman, CEO of MediSwipe, Inc.

"It was always our plan with MediSwipe as we continue to add patients to our health record portals and software applications to become the only meaningful partner to dispensaries across the states, and that we would be the natural pipeline and provider through our new distribution subsidiary for additional products including edibles, beverages and nutracueticals to complement our merchant services product which we have long been known for in this industry" added Friedman.

"CHILLO and C+SWISS have sold extremely well in dispensaries in the past but penetrating the market on a bigger scale always was a problem from a logistical standpoint for the Chill Drinks team. With this partnership with MediSwipe, Chill Drinks can get distribution into many dispensaries located in many states nationwide and sell great tasting functional beverages to many consumers," stated Marc Lewin, President of Chill Drinks.

About MediSwipe Inc.

MediSwipe Inc. ( provides innovative patient solutions for electronically processing transactions within the healthcare industry. MediSwipe provides terminal-based service packages and an integrated Web Portal add-ons for physicians, clinics, hospitals and medical dispensaries that include: digital patient records, Electronic Referrals, Credit/Debit Card merchant services, Check Guarantee and Accounts Receivable Financing.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.

CONTACT: MediSwipe Inc. 248.262.6850 info@mediSwipe.comSource:MediSwipe, Inc.